Research in this area remains limited but emerging evidence provides some guidance
Understanding the research landscape Responsible regenerative peptide use requires honest assessment of where the evidence stands
CD, n=258) who were prescribed a GLP1RA (liraglutide, semaglutide, tirzepatide) at least twice, identified on the Mayo Clinic Platform, included in this study, and matched with controls with IBD but not treated with GLP1RA
If thats the case, the author writes in the title of the paper, growing retractions are (mostly) a good sign. *** Retractions overall are up, but according to the study if we limit our analysis only to journals that issue retractions, the number of retractions per journal has not increased
The robustness of the tree topologies was assessed by bootstrap analysis implemented in PHYML (500 replicates)